Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Blood (2019) 134 (Supplement_1): 2747.

https://doi.org/10.1182/blood-2019-130210

Published: 2019

Journal Articles

MLL-USP2 : An Underestimated New Entity of MLL -Rearranged Leukemia Identified By NGS Analysis

Claus Meyer, PhD, Bruno Lopes, PhD, Aurélie Caye-Eude, PharmD, Hélène Cavé, PharmD, PhD, Chloé Arfeuille, PhD, Rosemary Sutton, PhD, Nicola Venn, BSc, Patrizia Larghero, PhD, Seung Hwan Oh, MD, Grigory Tsaur, MD PhD, Marketa Zaliova, Jan Zuna, Vesa Juvonen, PhD, Renate Panzer-Grümayer, MD, Grazia Fazio, PhD, Giovanni Cazzaniga, PhD, Mariana Emerenciano, PhD, Rolf Marschalek, PhD

Blood (2018) 132 (Supplement 1): 3920.

https://doi.org/10.1182/blood-2018-99-112594

Published: 2018

Journal Articles

Application of Real-Time PCR for the Detection of BCR-ABL1 -like Group in Pediatric Acute Lymphoblastic Leukemia Patients

Grigory Tsaur, MD PhD, Tatiana Muhacheva, PhD, Sergey Kovalev, PhD, Alexander Druy, MD PhD, Petr Sibiryakov, Yulia Olshanskaya, MD PhD, Olga Soldatkina, Alexander Popov, MD PhD, Anna Vlasova, MD, Oleg Arakaev, MD, Tatiana Verzhbitskaya, MD PhD, Leonid Saveliev, Larisa Fechina, MD PhD

Blood (2018) 132 (Supplement 1): 1376.

https://doi.org/10.1182/blood-2018-99-115035

Published: 2018

Journal Articles

Applicability and Prognostic Significance of Flow Cytometric Cerebrospinal Fluid Investigation in Children with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, MD PhD, Julia Roumiantseva, MD PhD, Svetlana Lagoiko, Grigory Tsaur, MD PhD, Olga Khlebnikova, MD, Olga Streneva, MD PhD, Alexander Karachunsky, MD PhD, Larisa Fechina, MD PhD

Blood (2017) 130 (Supplement 1): 3984.

https://doi.org/10.1182/blood.V130.Suppl_1.3984.3984

Published: 2017

Journal Articles

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, Grigory Tsaur, MD PhD, Egor Shorikov, MD PhD, Liudmila Movchan, MD PhD, Mikhail Belevtsev, MD PhD, Anatoly Kustanovich, PhD, Olga Streneva, MD PhD, Olga Khlebnikova, MD, Natalia Myakova, Dmitry Litvinov, MD PhD, Konstantin Kondratchik, MD, Elmira Boychenko, MD PhD, Olga Aleinikova, PhD, Michael Maschan, MD PhD, Alexander Karachunskiy, MD PhD, Larisa Fechina, MD PhD

Blood (2016) 128 (22): 1731.

https://doi.org/10.1182/blood.V128.22.1731.1731

Published: 2016

Journal Articles

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Alexander Popov, MD PhD, Grigory Tsaur, MD PhD, Tatiana Verzhbitskaya, MD PhD, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 5359.

https://doi.org/10.1182/blood.V124.21.5359.5359

Published: 2014

Journal Articles

Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL- rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol

Grigory Tsaur, MD PhD, Alexander Popov, MD PhD, Tatyana Riger, MD, Alexander Solodovnikov, MD PhD, Tatyana Nasedkina, PhD, Anatoly Kustanovich, PhD, Sergey Tsvirenko, Prof, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 2404.

https://doi.org/10.1182/blood.V124.21.2404.2404

Published: 2014

Journal Articles

Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment

Alexander Popov, MD, PhD, Barbara Buldini, Paola de Lorenzo, Emanuella Giarin, Annamaria Di Meglio, Franco Locatelli, Rosanna Parasole, Larisa Fechina, Grigory Tsaur, MD, PhD, Andrea Biondi, MD, Maria Grazia Valsecchi, Giuseppe Basso

Blood (2013) 122 (21): 1333.

https://doi.org/10.1182/blood.V122.21.1333.1333

Published: 2013

Journal Articles

MLL genomic DNA Breakpoints In Infant Acute Leukemia

Grigory Tsaur, MD, PhD, Claus Meyer, Alexander Popov, Olga Plekhanova, Anatoly Kustanovich, Alena Volochnik, Tatyana Riger, Anna Demina, Alexander Druy, Elena Fleischman, Olga Sokova, Yulia Olshanskaya, Olga Streneva, Egor Shorikov, Leonid Saveliev, Rolf Marschalek, Larisa Fechina

Blood (2013) 122 (21): 1350.

https://doi.org/10.1182/blood.V122.21.1350.1350

Published: 2013

Journal Articles

Does ATRA Confirm to Play a Role in the Better Relapse Free Survival of Infants with Acute Lymphoblastic Leukemia?

Larisa Fechina, MD, Egor Shorikov, MD, Olga Streneva, MD, Olga Khlebnikova, MD, Igor Vyatkin, MD, Larisa Vakhonina, MD, Grigory Tsaur, MD, Alexander Popov, Leonid Saveliev, Natalia Miakova, MD, Dmitry Litvinov, MD, Konstantin Kondratchik, MD, Anastasia Shamardina, MD, Elmira Boichenko, MD, Karapet Aslanyan, MD, Elena Lapotentova, MD, Olga Aleinikova, MD, Alexander Karachunsky, MD, Alexander Roumyantsev, MD

Blood (2011) 118 (21): 1515.

https://doi.org/10.1182/blood.V118.21.1515.1515

Published: 2011

Journal Articles

Minimal Residual Disease Monitoring by Quantification of Fusion Gene Transcripts In Infant with MLL- rearranged Acute Lymphoblastic Leukemia Treated by MLL-Baby Protocol

Grigory Tsaur, MD, PhD, Alexander Popov, Tatyana Nasedkina, Olga Kalennik, Anatoly Kustanovich, Olga Aleinikova, Tatyana Riger, Yulia Yakovleva, Anna Ivanova, Egor Shorikov, Leonid Saveliev, Larisa Fechina, MD

Blood (2010) 116 (21): 2731.

https://doi.org/10.1182/blood.V116.21.2731.2731

Published: 2010

Journal Articles

Qualitative and Quantitative Concordance of Minimal Residual Disease Data Assessed by Multicolor Flow Cytometry and PCR of Fusion Gene Transcripts In Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Alexander Popov, Grigory Tsaur, MD, PhD, Tatiana Verzhbitskaya, Tatyana Riger, Yulia Yakovleva, Anna Ivanova, Alexander Druy, Egor Shorikov, Leonid Saveliev, Larisa Fechina, MD

Blood (2010) 116 (21): 1720.

https://doi.org/10.1182/blood.V116.21.1720.1720

Published: 2010

Journal Articles

Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib.

Grigory Tsaur, MD, PhD, Anna Ivanova, Alexander Popov, Yulia Yakovleva, Tatyana Riger, Olga Plekhanova, Yulia Ivanets, Andrey Misyurin, Marina Suchkova, Egor Shorikov, Leonid Saveliev, Larisa Fechina, MD

Blood (2010) 116 (21): 3422.

https://doi.org/10.1182/blood.V116.21.3422.3422

Published: 2010

Journal Articles

Immunological Shift On Day 15 of Remission Induction in Children with CD10-Positive B-Cell Precursor ALL Treated by ALL-MB 2008 Protocol.

Alexander Popov, MD, Tatiana Verzhbitskaya, MD, PhD, Grigory Tsaur, MD, PhD, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2009) 114 (22): 2650.

https://doi.org/10.1182/blood.V114.22.2650.2650

Published: 2009

Journal Articles

WT1 Gene Expression Limited Application for MRD Monitoring in AML Patients Carrying MLL Rearrangements.

Grigory Tsaur, MD, PhD, Alexander Popov, MD, PhD, fellow, Alexander Druy, Anna Ivanova, Tatyana Riger, MD, Olga Plekhanova, Yulia Svechnikova, MD, Egor Shorikov, MD, PhD, Claus Meyer, Rolf Marschalek, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2009) 114 (22): 4700.

https://doi.org/10.1182/blood.V114.22.4700.4700

Published: 2009

Journal Articles

MRD Monitoring in AML Patients with MLL-MLLT4 by Quantification of Fusion Gene Transcripts and Genomic Chromosomal Breakpoint Sequences

Grigory Tsaur, MD, PhD, Anna Ivanova, Olga Plekhanova, Tatyana Riger, MD, Yulia Yakovleva, MD, Alexander Popov, PhD, Yulia Svechnikova, MD, Olga Makarova, MD, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Claus Meyer, PhD, Rolf Marschalek, Larisa Fechina, MD, PhD

Blood (2008) 112 (11): 4888.

https://doi.org/10.1182/blood.V112.11.4888.4888

Published: 2008

Journal Articles

Molecular Remission in MLL/AF4-Positive Infant Leukemia Treated with the All Trans-Retinoic Acid Based MLL-Baby Protocol.

Grigory Tsaur, MD, PhD, Elizaveta Semenikhina, Anna Ivanova, Tatiana Nasedkina, PhD, Alexander Popov, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2007) 110 (11): 4254.

https://doi.org/10.1182/blood.V110.11.4254.4254

Published: 2007

NARROW

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

MLL-USP2 : An Underestimated New Entity of MLL -Rearranged Leukemia Identified By NGS Analysis

Application of Real-Time PCR for the Detection of BCR-ABL1 -like Group in Pediatric Acute Lymphoblastic Leukemia Patients

Applicability and Prognostic Significance of Flow Cytometric Cerebrospinal Fluid Investigation in Children with Acute Lymphoblastic Leukemia

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL- rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol

Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment

MLL genomic DNA Breakpoints In Infant Acute Leukemia

Does ATRA Confirm to Play a Role in the Better Relapse Free Survival of Infants with Acute Lymphoblastic Leukemia?

Minimal Residual Disease Monitoring by Quantification of Fusion Gene Transcripts In Infant with MLL- rearranged Acute Lymphoblastic Leukemia Treated by MLL-Baby Protocol

Qualitative and Quantitative Concordance of Minimal Residual Disease Data Assessed by Multicolor Flow Cytometry and PCR of Fusion Gene Transcripts In Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Evaluation of BCR-ABL/ABL Ratio Increase That Corresponds to BCR-ABL Mutation In Chronic Myeloid Leukemia Patients Treated by Imatinib.

Immunological Shift On Day 15 of Remission Induction in Children with CD10-Positive B-Cell Precursor ALL Treated by ALL-MB 2008 Protocol.

WT1 Gene Expression Limited Application for MRD Monitoring in AML Patients Carrying MLL Rearrangements.

MRD Monitoring in AML Patients with MLL-MLLT4 by Quantification of Fusion Gene Transcripts and Genomic Chromosomal Breakpoint Sequences

Molecular Remission in MLL/AF4-Positive Infant Leukemia Treated with the All Trans-Retinoic Acid Based MLL-Baby Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only